Research & publications
 Health Insurers: The Customer Engagement Imperative
A confluence of forces is forcing health insurance companies to take bold steps to ensure their long-term viability while reducing the overall cost of healthcare. Insurers must improve the customer experience and capitalize on their uniquely rich data.
[Read Article]
 Winning the Battle for Consumer Healthcare
A new “consumer healthcare” segment is emerging halfway between mass retail-based consumer goods and pharmaceuticals—and giants in these two industries are forming a new battleground. The winners in this new segment will likely use a mixed model that features capabilities from each industry.
[Read Article]
 Pharmaceutical Markets: The New Price of Admission
Even as healthcare budgets are rising, drug sales in most developed markets are forecast to be flat. With such a thin pipeline, it is essential for pharmaceutical companies to make the best of their current portfolios and pay the new price of admission.
[Read Article]
The Latest Hype, or a Real Opportunity: Is Mobile the New Great Hope for Pharma?
5 September 2001 — pharmaphorum
One of the biggest stories around is mobile health, and pharma companies are well placed to realize value. A.T. Kearney has identified three key success factors for mobile health service, plus several plays that pharma needs to consider.
By Michael Thomas and Jonathan Anscombe
By Vishal Bhandari, Axel Erhard, Saurabh Tejwani, Mike Wise
[Read Article]
Healthcare Out of Balance: How Global Forces Will Reshape the Health of Nations
Global forces are reshaping the healthcare industry, and many long-established social contracts between governments and citizens are being challenged in the process. As many deeply held beliefs begin to waiver, it's time to revisit the role of the state in healthcare.
[Read Article]
Will China Lose Its Cost-Competitiveness in Pharma Manufacturing by 2015?
September 2010 — Life Science Leader
With macro trends impacting China's pharmaceutical manufacturing, Western companies have a range of options to stay cost-competitive, but the solution will need to be aligned with the company's strategy, supply chain capabilities, and product / supplier portfolio — and the solutions have varying degrees of reward and implementation complexity.
By Axel Erhard, Vishal Bhandari, and Saurabh Tejwani
[Read Article]
Mergers and Acquisitions in the Healthcare Industry
Uncertainty in the healthcare industry is leading to more M&A. What can pharmaceutical firms do to prepare?
[Read Article]
How to Unlock $43 Billion in Value by Improving Working Capital Management
April 2010 — PharmaPro
Raising the average working capital performance level of pharmaceutical companies to that of the industry’s top quartile would result in freeing up $43B of cash -- money which could be productively invested in research, marketing and other value generating initiatives.
By Carol Cruickshank, David Hanfland, Paul Inglis, Shiv Shivaraman
[Read Article]
Patient recruitment strategies for success
Companies often experience significant delays in completing clinical trials; in many cases up to one-third of originally planned timelines.
[Read Article]
A Healthy Regimen for Pharmaceuticals
It’s a $40 billion question: How can U.S. pharma companies close the gap between revenues and expectations?
[Read Article]
Healing Mexico's Health-Care System
Supply chain improvements, a time-tested tool for corporate health, helped the Mexican government deliver medicine more efficiently.
[Read Article]
Improving the Medicine Supply Chain
Nations under pressure to reduce health care budgets and costs might learn a few lessons from Mexico.
[Read Article]
RFID/EPC: Managing the Transition (2004-2007)
Radio frequency identification (RFID) has created a storm--capturing the attention and, in some cases, the ire of industries and consumers.
[Read Article]
Thinking Beyond the Next Blockbuster
The combination of cutting-edge science, dogged persistence and a bit of luck artfully mixed to create magic. But as the era of powerhouse treatments transitions into its next season, the magic is more elusive and costly.
[Read Article]
Make Your Move: Taking Clinical Trials to the Best Location
Should pharmaceutical companies augment their offshore strategies by performing some clinical trials in lower-cost locations? The short answer is yes.
[Read Article]
Destination Latin America: A Near-Shore Alternative
Latin America has arrived front and center as a desirable offshore destination. As a “near-shore” destination, Latin America has what many U.S. and some European companies want: low-cost Spanish-language capability and a growing, relatively low-cost, skilled bilingual workforce.
[Read Article]
Nanotechnology Is More than a Hot New Label
Nanotechnology is still in its early days, but it’s already clear that this will be the next game-changing technology across industries.
[Read Article]
Smart Boxes
As more companies implement RFID technology in their over-ocean supply chains, success factors are becoming clear.
[Read Article]
Fourth Annual Pharmaceuticals Roundtable
The Roundtable delegates addressed some of the toughest issues facing the pharmaceutical industry today. After decades of exceptional growth, the industry is now coping with a period of slower earnings expansion.
[Read Article]
Outsourcing Beyond the Comfort Zone
Challenges are escalating. Investors are accustomed to double-digit growth, which is a goal pharmaceutical companies will be hard-pressed to achieve as patents expire, blockbuster launches decline, and large customers, especially governments, step-up pricing pressures on the industry.
[Read Article]
Busting the Myth of Pharma RFID
Words like “counterfeiting” and “out of stock” are anathema to any industry, but for pharmaceuticals the implications are particularly serious. Radio frequency identification, or RFID, has the potential to nearly eradicate such issues. The idea of tagging and tracking the whereabouts of drugs has some intrigued, some alarmed—and most somewhat confused. What’s the real story?
[Read Article]
Third Annual Pharmaceuticals Roundtable
A.T. Kearney is proud to have recently served as a lead sponsor in one of the pharmaceutical industry's premier annual events, the Third Annual Pharmaceuticals Roundtable, presented by Economist Conferences. The roundtable, which took place in November 2003, mapped the industry's evolving landscape and explored what drug makers can do to jump start growth.
[Read Article]
Outsourcing among Pharmaceutical and Biotech Firms
For pharma and biotech companies, outsourcing is a means to improving financial and operating performance.
[Read Article]
Pharma Explores Uncharted Territory
The time is right for pharma companies to reach beyond their boundaries and tap into the benefits of global outsourcing, even for R&D.
[Read Article]
|
